Letter to the Editor

SERUM-FREE MEDIUM FOR LONG-TERM GROWTH, FREEZING, CLONING AND FUSION OF MYELOMAS AND HYBRIDOMAS
Dear Editor: A number of laboratories and companies have reported on the development of serum-free media for the growth of myelomas and hybridomas in tissue culture (1-4,6-9). Due to the different growth requirements of different cell lines, these serum-free media generally have not been broadly applicable. For example, HB101 (Hana Biologies) supported the growth of SP2/0 cells, SP2/O-derived hybridomas, human-human hybridomas, etc., but not NS-I and NS-l-derived hybridomas (6); the SFH medium described by Kovar and Franek (4) (5) . It was shown that successful growth of hybridoma in a serum-free medium in short-term culture did not mean successful adaptation to longterm cultivation in the serum-free medium (4) . In the present study it was confirmed that DMI could be successfully used to long-term P3U1  96  26  50  28  63  983  96  35  37  51  49  Hybfidoma  41RF5  96  38  48  51  70  13F3  96  20  25  25  28 culture a variety of cell lines tested (Table 1) . Although to date a number of serum-free media have been described, the cell densities in these media mostly were not superior to 106 cells/ml (1, 4, 6, 8) .
The present results showed that the densities of all cell lines passaged in DMI were more than 130 X 104 cells/ml when the death rate was less than 10% (Table 1) , and SP2/O ceils once reached a maximal density of 299 × 104 cells/ml. In addition, all tested 8 myeloma and hybridoma cell lines growing in DMI could be frozen in the absence of serum for storage in liquid nitrogen with quantitative serum-free cell recovery (data not shown). If the cells growing in the conventional medium containing 15% newborn calf serum (RPS15) were frozen with DMI for storage and, 2 weeks later, resurrected with RPS15 for reculture, cell recovery was similar to the conventional freezing and resurrection with 20% serum-supplemented medium (RPS20). Monoclonal antibody (mAb) production at high titers is a major goal of hybridoma technology. The most important factor in determining the utility of serum-free media in hybridoma euhure is whether mAb secretion is impaired by the removal of serum components. Our experimental results showed that the hybridoma cells cultured in DMI continued to secrete mAbs at levels similar to those obtained in RPS15 (data not shown).
Of evaluating the quantity of serum-free media, one is to test the ability of a serum-free medium to support the clonal growth from the single cell stage. McHugh et al. (6) demonstrated that the cloning efficiencies of SP2/0 and SP2/O-derived hybridomas in HB101 medium ranged from 1 to 3% as compared to 69-90% in serum-supplemented medium. Shacter (8) reported that the cloning efficiency of a hybridoma in SFM medium was 20% (9/48), Mouse-rat fusion (I) and mouse-mouse fusion (II); baverage number of colonies per well.
sensitized mouse spleen cells with myeloma cell lines P3-U1, Ag8.653 or NS-1. The result presented here has confirmed that DMI medium could be used in the cell fusions of immunized rat or mouse spleen cells with SP2/0 or P3U 1 myelomas either passaged in DMI medium or obtained from the subcutaneous somatic neoplasm in BALB/c mice with a maximal fusion efficiency of 100% (Table 3 ) and in the isolation of antibody-secreting hybridomas (data not shown). Thus, it is concluded that DMI medium may be broadly applicable.
whereas that obtained in the presence of 10% serum was 50% (48/96). Our data (Table 2) showed that the cloning effciencies (number of wells with hybrids) obtained in DMI ranged from 21 to 45% as compared to 26 to 56% in RPS15, and that the number of clones grown in the plates varied from 26 to 53% in DMI as compared to 29 to 86% in RPS15.
The production of antibody-secreting hybridomas from the fusions of mouse myeloma cells with spleen cells in serum-free medium has a number of practical advantages (3). However, whether or not serum-free media developed specifically for parental myeloma lines and/or established hybridoma lines can be used in the cell fusion between immunized spleen ceils and myeloma cell lines and subsequently in the isolation of hybridomas directly after the fusion is less clear. Kawamoto et al. (3) reported that the KSLM medium could be used in the cell fusion and then in the isolation of antibody-secreting hybridomas. When using NS-1 as parental cells, the fusion effciencies ranged from 52 to 54%, while for NS-1-503 partner, the fusion efficiencies varied from 85 to 92%. Yabe et al. (9) indicated that the NYSF-404 medium was able to use for the selection of antibody-producing hybridomas after fusion of antigen-
